Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-13 · accession 0000875320-26-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-13 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $487.76 | -1,393 | 8,734 | -14% | -$679.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-13 | F | D | 1,393 | $487.76 | 8,734 | D | — | — |